Clinical Trial Update: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Study to Evaluate the Safety and Efficacy of Uterine Blood Mesenchymal Stem Cells Injection for the Treatment of Severe Pneumonia Caused by Viruses [Phase 1]

View source ↗

Summary

A multicenter Phase 1 study (randomized, double-blind, placebo-controlled) evaluating safety and efficacy of uterine blood mesenchymal stem cells injections for…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pneumonia

Drugs mentioned

• Uterine Blood Mesenchymal Stem Cells Injection

Snippet

Sponsor: Ruijin Hospital | Conditions: Severe Viral Pneumonia(Not Include COVID-19) | Phase 1 | Status: RECRUITING